Cowen Investment Management’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History

Cowen Investment Management’s Portfolio EUCRW Stock Details EUCRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-33,333	Closed	-$1.35K	–	117
2023 Q1	$1.35K	Hold	33,333	–	–	﹤0.01%	114
2022 Q4	$1.85K	Buy	+33,333	New	+$1.19K	﹤0.01%	193

Cowen Investment Management's EUCRW Position: Q2 2023 in Review

Cowen Investment Management sold out of Eucrates Biomedical Acquisition Corp. Warrant (EUCRW) in Q2 2023, closing a stake of 33,333 shares — an estimated $1.35K sold.

Cowen Investment Management first reported a position in EUCRW in Q4 2022 and held it in 2 quarters. The position peaked at $1.85K in Q4 2022. 0 funds tracked by Wall St. Rank hold EUCRW as of Q2 2023.

Cowen Investment Management reported no remaining Eucrates Biomedical Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Cowen Investment Management sold 33,333 Eucrates Biomedical Acquisition Corp. Warrant shares in Q2 2023, an estimated $1.35K.
Cowen Investment Management first reported a position in Eucrates Biomedical Acquisition Corp. Warrant in Q4 2022 and held it in 2 quarters.
Cowen Investment Management's Eucrates Biomedical Acquisition Corp. Warrant position peaked at $1.85K in Q4 2022.
0 funds tracked by Wall St. Rank held Eucrates Biomedical Acquisition Corp. Warrant as of Q2 2023.

Based on Cowen Investment Management's 13F filing for Q2 2023, filed 15 Aug 2023.